Penumbra

medical device company in Alameda, California

NYSE ISIN US70975L1070 SEC CIK 1321732 LEI 549300RGE06P3ECANU72
Follow Penumbra Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $410.1M +15.6% vs same quarter last year
Net income $42.3M −7.8% vs same quarter last year
EPS, diluted $1.07 −8.5% vs same quarter last year
Operating cash flow $41.5M −28.8% vs same quarter last year
Revenue by quarter
$315.5M
$324.1M
$339.5M
$354.7M
$385.4M
$374.8M
$390M
$410.1M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5BFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$1.4B$177.7M
FY24$1.2B$14M
FY23$1.1B$91M
FY22$847.1M−$2M
FY21$747.6M$5.3M
FY20$560.4M−$15.7M
FY19$547.4M$48.5M
FY18$444.9M$6.6M
FY17$333.8M$4.7M
FY16$263.3M$14.8M
FY15$186.1M$2.4M
FY14$125.5M-
FY13$88.8M$4.1M
FY12--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%60%80%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2567.1%13.5%12.7%
FY2463.2%0.8%1.2%
FY2364.5%6.9%8.6%
FY2263.2%0.7%−0.2%
FY2163.6%−1%0.7%
FY2060.3%−6.9%−2.8%
FY1968%8.7%8.9%
FY1865.7%−0.2%1.5%
FY1765.1%0.3%1.4%
FY1664.9%−0.5%5.6%
FY1566.7%2.2%1.3%
FY1466%2.4%-
FY1365.1%−1.3%4.6%
FY12---
Free cash flowOperating cash flow minus capital expenditure
−$100M$0$100M$200MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$174.9M
FY24$147.3M
FY23$82.1M
FY22−$75M
FY21−$11.7M
FY20−$58M
FY19$4.5M
FY18$19.2M
FY17$159K
FY16−$26.4M
FY15−$26.2M
FY14−$10.3M
FY13−$4.2M
FY12-
Returned to shareholdersDividends paid and shares bought back
$0$50M$100M$150MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$0
FY24$100.4M
FY23$0
FY22$0
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Penumbra
  • Healthcare median
−100%−75%−50%−25%0%25%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPenumbraHealthcare median
FY2512.7%−30.6%
FY241.2%−47%
FY238.6%−58%
FY22−0.2%−80.4%
FY210.7%−71.8%
FY20−2.8%−62.2%
FY198.9%−46.2%
FY181.5%−49.6%
FY171.4%−45.9%
FY165.6%−36%
FY151.3%−37.8%
FY14-−35.5%
FY134.6%−37.1%
FY12-−29.1%